Login


TI Ref No : 508457814
Description : Conclusion Of Non-exclusive Discount Agreements Pursuant To Section 130a Paragraph 8/130c Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Olanzapine (n05ah03), Without Solid Oral Dosage Forms Within The Framework Of A So-called O
Date : 2024-09-19
Deadline : 2026-08-31
Document Type : Tenders
View Details
Whats app